The Determination of Presynaptic PA2 Values of Yohimbine and Phentolamine on the Perfused Rat Heart Under Conditions of Negligible Autoinhibition
Overview
Authors
Affiliations
1 Rat isolated perfused hearts with the right sympathetic nerves attached were loaded with [3H]-(-)-noradrenaline. The nerves were stimulated with up to 40 trains of 10 pulses every min at 1 Hz, and the evoked increases of [3H-]noradrenaline overflow into the perfusate, of right atrial tension development and ventricular beating frequency were measured. 2 Oxymetazoline inhibited the evoked transmitter overflow (IC50: 10 nM) and decreased the postsynaptic responses in a concentration-dependent manner. It behaved as a full against in abolishing the evoked transmitter overflow. 3 Yohimbine up to 1 microM neither enhanced the evoked [3H]-noradrenaline overflow nor the postsynaptic parameters. Phentolamine (1 microM) caused a transient, minor (less than 30%) increase in [3H]-noradrenaline overflow. 4 Yohimbine (0.03-1.0 microM) and phentolamine (0.1-5.0 microM) shifted to the right the concentration-response curve of oxymetazoline for the inhibition of [3H]-noradrenaline overflow in response to nerve stimulation without depressing the maxima. The pA2 values were 7.82 and 7.52, respectively. 5 Yohimbine (0.1 microM) also antagonized the decrease induced by oxymetazoline in the postsynaptic responses to nerve stimulation. 6 The results confirm the existence of presynaptic inhibitory alpha 2-adrenoceptors at the adrenergic nerve fibres of the rat heart in vitro. Under the stimulation and perfusion conditions selected, the released endogenous transmitter apparently does not activate a negative feedback mechanism, thus permitting the determination of pA2 values.
One hundred years of adrenaline: the discovery of autoreceptors.
Bennett M Clin Auton Res. 1999; 9(3):145-59.
PMID: 10454061 DOI: 10.1007/BF02281628.
Alpha 2C-adrenoceptor-modulated release of noradrenaline in human right atrium.
Rump L, Bohmann C, Schaible U, Schollhorn J, Limberger N Br J Pharmacol. 1995; 116(6):2617-24.
PMID: 8590979 PMC: 1909128. DOI: 10.1111/j.1476-5381.1995.tb17216.x.
Muscholl E Naunyn Schmiedebergs Arch Pharmacol. 1995; 351(2):164-72.
PMID: 7770098 DOI: 10.1007/BF00169330.
Limberger N, Funk L, Trendelenburg A, Starke K Naunyn Schmiedebergs Arch Pharmacol. 1995; 352(1):31-42.
PMID: 7477423 DOI: 10.1007/BF00169187.
Limberger N, Starke K Naunyn Schmiedebergs Arch Pharmacol. 1984; 325(3):240-6.
PMID: 6145100 DOI: 10.1007/BF00495950.